TD Cowen’s Jaret Seiberg warns the midterm elections in November 2026 could delay a key financial regulation until the next year.

When the U.S. Bureau of Labor Statistics reported that its most recent measure of consumer price inflation was just 2.7%, it came as a surprise to many. The consensus prediction on Wall Street had been 3.1%.

Wall Street analysts expect the S&P 500 will see earnings growth beyond technology in 2026, with the index’s current valuation making it “essential” for the U.S. economy to keep growing at “a reliable clip through the year,

The stock market faces several headwinds in 2026, but Wall Street still expects another year of double-digit gains.

U.S. stock index futures were muted on Tuesday as investors took a breather after Wall Street posted its biggest intraday gains in weeks in the previous session, while markets braced for a data-heavy week of labor reports.

Corporate profits and falling interest rates may be enough to lift the S&P 500 to a fourth-straight year of gains, the longest such streak in nearly two decades.

D-Wave Quantum (QBTS) says it has successfully completed an industry first: scalable, on-chip cryogenic control of qubits.

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.

Wedbush's Dan Ives sees a $6 trillion path for the chip giant, but DA Davidson's Gil Luria warns that the "AI party" could face a hangover if the data center cycle begins to roll over.

Hilton faces DHS ire after ICE agents were denied rooms at Minneapolis hotel. Hawaiian Electric reaches $47.75M shareholder settlement over wildfires. Clarivate unveils 2026 Drugs to Watch.